"We remain bullish on Canadian licensed producers and consider the following companies to be acquisition targets: Emblem (EMC.V) (EMMBF), Organigram (OGI.V) (OGMRF), Emerald Health (EMH.V) (EMHTF), Invictus MD Strategies (IMH.V) (IVITF), and Supreme Pharmaceuticals (FIRE.V) (SPRWF)."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.